Japan's stock benchmark Nikkei recouped early losses on Wednesday to close marginally higher, but sentiment remained subdued over stalled COVID-19 vaccine trials and lack of agreement on additional U.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback